glp-1 industry What is the future of trends: PwC GLP-1: Transforming weight loss and
Description
That is the industry lining up behind the problem
Tirzepatide was approved by the FDA for the treatment of diabetes in May 2022 and a few months later in the European Union, Canada and Australia
If you are struggling with dietary compliance, say so
Based on the available evidence at the time, the ASA released a statement advising holding GLP-1 RAs based on their dosing schedule in patients undergoing any type of elective procedures
